Trial set to start on potential MND drug

By Tim Dornin
Updated May 25 2022 - 5:56am, first published 5:52am
Clinical trials are beginning of a drug that may help people with motor neurone disease.

A Perth-based biotechnology company is set to begin phase one clinical trials of a cancer drug for the treatment of motor neurone disease.



Get the latest Bathurst news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.